We are creating a shared value proposition for Flemingsberg in collaboration with Huddinge and Botkyrka municipalities, supported by Fabege, Hemsö, and the Clara Foundation. This joint initiative has been developed in consultation with the communication agency Gullers Grupp and is a result of the initiative from the Flemingsberg Science Foundation.

This year's Innovation and Collaboration Days in Flemingsberg focused on how innovation, research, and educational collaboration can contribute to a sustainable society, as well as the need for cultural industries in a growing neighborhood.

Earlier this week, Mitt i Stockholm reported the joyful news that they will be increasing the number of departures on the Södertälje commuter train during rush hours starting from Monday, October 30th. This means that the trains will run eight times per hour.

The Norwegian company, Circio Holding ASA, has established a Swedish subsidiary, Circio AB, in Flemingsberg, and they have recently expanded their facilities. The research group and activity level at the Karolinska Institutet grew, necessitating their acquisition of their own labs and offices at A Working Lab in Flemingsberg.

At Campus Flemingsberg, nearly 20,000 students study a wide range of subjects, from medical technology and healthcare, to humanities, police training, and music education. It is a place full of knowledge where the foundations of the future society are being laid, and after a pause of three years, the campus day is finally back. It's a day when students and professionals gather at Campus Flemingsberg to kick off the autumn semester together.

At the end of the summer, Josefine Bresmar started as Flemingsberg Science’s new Director of Communications. One of Josefine’s main tasks will be to develop the Flemingsberg Business Community network.

Sprint Bioscience has licensed its VADA cancer programme to US-based Day One Biopharmaceuticals. The deal is Sprint Bioscience’s largest to date and could be worth around SEK 3.4 billion. In the next two years, the two companies will take the steps towards clinical testing of a new cancer drug.

Bolagen fortsätter att strömma till A Working Lab (AWL) i Flemingsberg. Det som attraherar dem är främst flexibiliteten och de korta kontrakten, men också den starka forskningsinfrastrukturen i Flemingsberg.